本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Kura Oncology, Inc

8.43
+0.48006.04%
盤後8.31-0.1199-1.42%19:41 EDT
成交量:146.74萬
成交額:1,219.62萬
市值:7.32億
市盈率:-3.73
高:8.45
開:7.95
低:7.86
收:7.95
52周最高:21.57
52周最低:5.41
股本:8,679.72萬
流通股本:6,398.56萬
量比:0.78
換手率:2.29%
股息:- -
股息率:- -
每股收益(TTM):-2.2592
每股收益(LYR):-2.0193
淨資產收益率:-51.11%
總資產收益率:-22.93%
市淨率:2.40
市盈率(LYR):-4.17

資料載入中...

2024/05/02

重要事件披露

Form 8-K - Current report
2024/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/15

SEC問詢函

Form CORRESP - Correspondence
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

SEC問詢函

Form CORRESP - Correspondence
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/30

重要事件披露

Form 8-K - Current report
2024/01/26

重要事件披露

Form 8-K - Current report
2024/01/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/22

重要事件披露

Form 8-K - Current report
2023/11/02

重要事件披露

Form 8-K - Current report
2023/11/02

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/22

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/02

重要事件披露

Form 8-K - Current report